Search Results - "Marton, Matthew J."

Refine Results
  1. 1

    Concordance between single-nucleotide polymorphism-based genomic instability assays and a next-generation sequencing-based homologous recombination deficiency test by Cristescu, Razvan, Liu, Xiao Qiao, Arreaza, Gladys, Chen, Cai, Albright, Andrew, Qiu, Ping, Marton, Matthew J

    Published in BMC cancer (14-12-2022)
    “…We evaluated the performance of single-nucleotide polymorphism (SNP) genotyping arrays OncoScan (Thermo Fisher Scientific, San Diego, CA) and Infinium…”
    Get full text
    Journal Article
  2. 2

    Navigating the rapids: the development of regulated next-generation sequencing-based clinical trial assays and companion diagnostics by Pant, Saumya, Weiner, Russell, Marton, Matthew J

    Published in Frontiers in oncology (17-04-2014)
    “…Over the past decade, next-generation sequencing (NGS) technology has experienced meteoric growth in the aspects of platform, technology, and supporting…”
    Get full text
    Journal Article
  3. 3

    Pre-Analytical Considerations for Successful Next-Generation Sequencing (NGS): Challenges and Opportunities for Formalin-Fixed and Paraffin-Embedded Tumor Tissue (FFPE) Samples by Arreaza, Gladys, Qiu, Ping, Pang, Ling, Albright, Andrew, Hong, Lewis Z, Marton, Matthew J, Levitan, Diane

    “…In cancer drug discovery, it is important to investigate the genetic determinants of response or resistance to cancer therapy as well as factors that…”
    Get full text
    Journal Article
  4. 4

    HCV genotyping from NGS short reads and its application in genotype detection from HCV mixed infected plasma by Qiu, Ping, Stevens, Richard, Wei, Bo, Lahser, Fred, Howe, Anita Y M, Klappenbach, Joel A, Marton, Matthew J

    Published in PloS one (01-04-2015)
    “…Genotyping of hepatitis C virus (HCV) plays an important role in the treatment of HCV. As new genotype-specific treatment options become available, it has…”
    Get full text
    Journal Article
  5. 5

    Data Interoperability of Whole Exome Sequencing (WES) Based Mutational Burden Estimates from Different Laboratories by Qiu, Ping, Pang, Ling, Arreaza, Gladys, Maguire, Maureen, Chang, Ken C N, Marton, Matthew J, Levitan, Diane

    “…Immune checkpoint inhibitors, which unleash a patient's own T cells to kill tumors, are revolutionizing cancer treatment. Several independent studies suggest…”
    Get full text
    Journal Article
  6. 6

    Analytical Validation of AmpliChip p53 Research Test for Archival Human Ovarian FFPE Sections by Marton, Matthew J, McNamara, Andrew R, Nikoloff, D Michele, Nakao, Aki, Cheng, Jonathan

    Published in PloS one (30-06-2015)
    “…The p53 tumor suppressor gene (TP53) is reported to be mutated in nearly half of all tumors and plays a central role in genome integrity. Detection of…”
    Get full text
    Journal Article
  7. 7

    Association of programmed death ligand 1 expression with prognosis among patients with ten uncommon advanced cancers by Steiniche, Torben, Ladekarl, Morten, Georgsen, Jeanette Bæhr, Andreasen, Simon, Busch-Sørensen, Michael, Zhou, Wei, Marton, Matthew J, Pruitt, Scott K, Jin, Fan, Liaw, Kai-Li

    Published in Future science OA (01-09-2020)
    “…PD-L1 expression and high levels of microsatellite instability (MSI-H) may predict response to checkpoint inhibitors, but their prevalence and prognostic value…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Development and validation of a clinical trial patient stratification assay that interrogates 27 mutation sites in MAPK pathway genes by Chang, Ken C N, Galuska, Stefan, Weiner, Russell, Marton, Matthew J

    Published in PloS one (21-08-2013)
    “…Somatic mutations identified on genes related to the cancer-developing signaling pathways have drawn attention in the field of personalized medicine in recent…”
    Get full text
    Journal Article
  11. 11

    Effects of Atmospheric Ozone on Microarray Data Quality by Fare, Thomas L, Coffey, Ernest M, Dai, Hongyue, He, Yudong D, Kessler, Deborah A, Kilian, Kristopher A, Koch, John E, LeProust, Eric, Marton, Matthew J, Meyer, Michael R, Stoughton, Roland B, Tokiwa, George Y, Wang, Yanqun

    Published in Analytical chemistry (Washington) (01-09-2003)
    “…A data anomaly was observed that affected the uniformity and reproducibility of fluorescent signal across DNA microarrays. Results from experimental sets…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Measuring Tumor Mutational Burden (TMB) in Plasma from mCRPC Patients Using Two Commercial NGS Assays by Qiu, Ping, Poehlein, Christian H., Marton, Matthew J., Laterza, Omar F., Levitan, Diane

    Published in Scientific reports (14-01-2019)
    “…Tumor tissue mutational burden (TMB) has emerged as a promising predictive biomarker for immune checkpoint therapy. Measuring TMB from circulating tumor DNA…”
    Get full text
    Journal Article
  14. 14

    Concordance between an FDA-approved companion diagnostic and an alternative assay kit for assessing homologous recombination deficiency in ovarian cancer by Wehn, Amy K., Qiu, Ping, Lunceford, Jared, Yarunin, Alexander, Cristescu, Razvan, Liu, Li, Roessler, Kyria, Bilke, Sven, Day, John R., Timms, Kirsten M., Weichert, Wilko, Marton, Matthew J.

    Published in Gynecologic oncology (01-05-2024)
    “…Authors evaluated the performance of a commercially available next-generation sequencing assay kit; this was based on genomic content from Illumina's TruSight™…”
    Get full text
    Journal Article
  15. 15

    Functional Interactions between Yeast Translation Eukaryotic Elongation Factor (eEF) 1A and eEF3 by Anand, Monika, Chakraburtty, Kalpana, Marton, Matthew J, Hinnebusch, Alan G, Kinzy, Terri Goss

    Published in The Journal of biological chemistry (28-02-2003)
    “…The translation elongation machinery in fungi differs from other eukaryotes in its dependence upon eukaryotic elongation factor 3 (eEF3). eEF3 is essential in…”
    Get full text
    Journal Article
  16. 16

    cDNA targets improve whole blood gene expression profiling and enhance detection of pharmocodynamic biomarkers: a quantitative platform analysis by Parrish, Mark L, Wright, Chris, Rivers, Yarek, Argilla, David, Collins, Heather, Leeson, Brendan, Loboda, Andrey, Nebozhyn, Michael, Marton, Matthew J, Lejnine, Serguei

    Published in Journal of translational medicine (25-09-2010)
    “…Genome-wide gene expression profiling of whole blood is an attractive method for discovery of biomarkers due to its non-invasiveness, simple clinical site…”
    Get full text
    Journal Article
  17. 17

    Practical Guidance for Implementing Predictive Biomarkers into Early Phase Clinical Studies by Marton, Matthew J., Weiner, Russell

    Published in BioMed research international (01-01-2013)
    “…The recent U.S. Food and Drug Administration (FDA) coapprovals of several therapeutic compounds and their companion diagnostic devices (FDA News Release, 2011,…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Gene expression profiling predicts clinical outcome of breast cancer by Friend, Stephen H, van 't Veer, Laura J, Dai, Hongyue, van de Vijver, Marc J, He, Yudong D, Hart, Augustinus A. M, Mao, Mao, Peterse, Hans L, van der Kooy, Karin, Marton, Matthew J, Witteveen, Anke T, Schreiber, George J, Kerkhoven, Ron M, Roberts, Chris, Linsley, Peter S, Bernards, René

    Published in Nature (London) (31-01-2002)
    “…Breast cancer patients with the same stage of disease can have markedly different treatment responses and overall outcome. The strongest predictors for…”
    Get full text
    Journal Article